Evaluation of Cosmetic outcome

How the breast looks (referred to as cosmesis) after lumpectomy and radiation is very important to a patient. Currently more intensive radiation regimens which may be associated with worse cosmesis than standard radiation are being studied. This study evaluated...

Feasibility Study of the Role of (SBRT):

This is a first in human study that evaluates a novel radiotherapy technology called SBRT in the treatment of breast cancer. Elderly women with small breast cancers will have five treatments with SBRT treatments over 2 weeks. They will...

The Uptake Study

Relatives of women with BRCA1 and BRCA2 breast cancer are at increased risk of developing breast cancer. Currently these women are offered genetic testing and counselling. In the UPTAKE study, relatives of women with hereditary breast cancer provided information...

Once a day partial breast irradiation

Daily breast irradiation for 3 to 4 weeks is standard treatment after lumpectomy for breast cancer. In a pilot study JCC researchers are studying a novel radiation regimen consisting of a daily treatment for only 5 days.

Comprehensive Genomic Characteristics

Triple (estrogen receptor, progesterone receptor, HER2) negative breast cancer has a poor prognosis and is associated with the genetic type called basal. In this study gene sequencing was conducted on frozen breast cancer samples from 10 triple negative...